These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 2494240)

  • 21. Efficacy, safety and duration of nitrate-free interval to prevent tolerance to transdermal nitroglycerin in effort angina.
    Gumbrielle T; Freedman SB; Fogarty L; Ogasawara S; Sobb P; Kelly DT
    Eur Heart J; 1992 May; 13(5):671-8. PubMed ID: 1618212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of a new transdermal nitroglycerin patch (Deponit 10) for stable angina pectoris.
    Greco R; D'Alterio D; Schiattarella M; Boccia A; Greco L; Marsico F
    Am J Cardiol; 1988 Mar; 61(9):44E-51E. PubMed ID: 3126635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intermittent transdermal nitroglycerin monotherapy in stable exercise-induced angina: a comparison with a continuous schedule.
    Ferratini M; Pirelli S; Merlini P; Silva P; Pollavini G
    Eur Heart J; 1989 Nov; 10(11):998-1002. PubMed ID: 2512162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sustained high-dose nitroglycerin transcutaneous patch therapy in angina pectoris: evidence for attenuation of effect over time.
    Frishman WH; Giles T; Greenberg S; Heiman M; Raffidal L; Soberman J; Laifer L; Nadelmann J; Lazar E; Strom J
    J Clin Pharmacol; 1989 Dec; 29(12):1097-105. PubMed ID: 2515215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute and sustained antianginal effects of nitroglycerin patches: objective evaluation with training-effect-eliminated exercise performance index.
    Dogar H; Güzelsoy D; Gültekin N; Gürses N; Demiroglu C
    Am J Cardiol; 1988 Mar; 61(9):39E-43E. PubMed ID: 3126634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relation of transdermal nitroglycerin efficacy with dosage in different subsets of patients.
    Rezaković DE
    Am J Cardiol; 1988 Mar; 61(9):59E-69E. PubMed ID: 3126637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transdermal nitroglycerin reduces the frequency of anginal attacks but fails to prevent silent ischemia.
    Rossetti E; Luca C; Bonetti F; Chierchia SL
    J Am Coll Cardiol; 1993 Feb; 21(2):337-42. PubMed ID: 8425995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic effects of transdermal nitroglycerin in stable angina pectoris: a within-patient, placebo-controlled study.
    Gibelli G; Negrini M; Bruno AM; Fiorini GL; Lambiase M; Magenta G; Corti D; Prina L; Pollavini PG; De Ponti C
    Int J Clin Pharmacol Ther Toxicol; 1989 Sep; 27(9):436-41. PubMed ID: 2509380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transdermal nitroglycerin in angina pectoris.
    Parker JO; Fung HL
    Am J Cardiol; 1984 Sep; 54(6):471-6. PubMed ID: 6433687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The day-long antianginal effectiveness of nitroglycerin patches. A double-blind study using dose-titration.
    Bassan M
    Chest; 1991 May; 99(5):1120-5. PubMed ID: 1902159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transdermal nitroglycerin in angina pectoris.
    Abrams J
    Eur Heart J; 1989 May; 10 Suppl A():11-9. PubMed ID: 2501090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discontinuous transdermal nitroglycerin as treatment for stable angina in the elderly: a double-blind multicentre study. The Transdermal TNG Trial Group of Istituto Nazionale Ricovero e Cura Anziani (I.N.R.C.A.).
    Paciaroni E; Luca C
    Eur Heart J; 1991 Oct; 12(10):1076-80. PubMed ID: 1782932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limited usefulness of intermittent nitroglycerin patches in stable angina.
    Waters DD; Juneau M; Gossard D; Choquette G; Brien M
    J Am Coll Cardiol; 1989 Feb; 13(2):421-5. PubMed ID: 2492322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antianginal effect of transdermal nitroglycerin and oral nitrates given for 24 hours a day in 2,456 patients with stable angina pectoris. The Italian Multicenter Study.
    Savonitto S; Motolese M; Agabiti-Rosei E
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):194-203. PubMed ID: 7620688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exercise capacity with transdermal nitroglycerin in patients with stable angina pectoris.
    Naafs MA; de Boer AC; Koster RW; Klazen CW; Dunning AJ
    Eur Heart J; 1984 Sep; 5(9):705-9. PubMed ID: 6437815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transdermal nitroglycerin efficacy in patients with chronic stable angina pectoris as related to sympathetic and renin-angiotensin-aldosterone activity.
    Muiesan ML; Agabiti-Rosei E; Romanelli G; Beschi M; Castellano M; Cefis M; Cerri B; Pollavini G; Muiesan G
    Eur Heart J; 1992 Jan; 13(1):15-21. PubMed ID: 1577025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of transdermal glyceryl trinitrate in the treatment of chronic stable angina pectoris.
    James MA; Walker PR; Papouchado M; Wilkinson PR
    Br Heart J; 1985 Jun; 53(6):631-5. PubMed ID: 3924081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute and chronic efficacy of low-dose nitroglycerin patches in stable angina pectoris.
    Rezaković DE; Lakatos S; Stalec J; Pavicić L
    Z Kardiol; 1986; 75 Suppl 3():90-5. PubMed ID: 3099489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Transdermal nitroglycerin in patients with stable angina].
    Ramires JA; Ghorayeb N; Mansur AP; Batlouni M; Oliveira SF; da Luz PL
    Arq Bras Cardiol; 1992 Feb; 58(2):141-7. PubMed ID: 1307460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Failure of transdermal nitroglycerin to improve chronic stable angina: a randomized, placebo-controlled, double-blind, double crossover trial.
    Crean PA; Ribeiro P; Crea F; Davies GJ; Ratcliffe D; Maseri A
    Am Heart J; 1984 Dec; 108(6):1494-500. PubMed ID: 6439019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.